Academic Journal
Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study
| Τίτλος: | Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study |
|---|---|
| Συγγραφείς: | Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan De Kam, Elizabeth Palmer, Lily Y. D. Wu, Sean T. Keane, William T. Fulton, Prista Hikmawati, Xun Meng, Paulina Filipaviciute, Anna Cutrina Pons, Kemi Oluwayi, Katarzyna Lis, Oliver Armfield, Murray A. Skinner, Matthew D. Heath, Simon J. Hewings, Matthias F. Kramer, Mohamed H. Shamji |
| Πηγή: | Allergy. |
| Στοιχεία εκδότη: | Wiley, 2025. |
| Έτος έκδοσης: | 2025 |
| Περιγραφή: | BackgroundA short‐course pre‐seasonal subcutaneous injection of PQ Grass is clinically effective for the treatment of allergic rhinitis, though its mechanism remains unclear. The aim of the study was to interrogate immunological mechanisms induced by PQ Grass conventional and extended regimens.MethodsA RDBPC exploratory field study involving participants that either received injections of PQ Grass with a cumulative dose of 27,600 SU conventional (six once weekly injections) or extended regimen (three once weekly injections followed by three once monthly injections) or placebo containing microcrystalline tyrosine (MCT) (placebo + MCT) or saline (placebo) was performed. Humoral, cellular, and molecular responses were assessed at baseline (V1), end of treatment, prior to grass pollen season (V12) and end of pollen season (V15). Immunoglobulin analyses and cellular/gene microarray analyses were performed in the sub‐study cohort consisting of PQ Grass Conventional (n = 25 and n = 10, respectively), PQ Grass Extended (n = 26 and n = 10, respectively), Placebo with MCT (n = 13 and n = 5, respectively), and Placebo (saline; n = 12 and n = 5, respectively).ResultsBoth PQ Grass regimens, conventional and extended, were associated with improvement in total combined scores (TCS) with a relative difference of −35.0% (p = 0.03) and −40.8% (p = 0.01) against placebo with MCT, respectively. Both PQ Grass treatment regimens were associated with increases in the sIgG4/sIgE ratio (all, p 1 (all, p 2 (all, p p p p p + Treg cells (p ConclusionsFor the first time, we highlight differential mechanisms of tolerance induction by PQ Grass, with the extended regimen being superior in modulating T cell compartments.Trail RegistrationTrial number: PQGrass309, EudraCT number: 2020‐000408‐13, Clinicaltrials.gov identifier: NCT04687059, and NCT05540717 |
| Τύπος εγγράφου: | Article |
| Γλώσσα: | English |
| ISSN: | 1398-9995 0105-4538 |
| DOI: | 10.1111/all.16640 |
| Rights: | CC BY |
| Αριθμός Καταχώρησης: | edsair.doi...........b805873b957f6cd805225b910a153128 |
| Βάση Δεδομένων: | OpenAIRE |
| ISSN: | 13989995 01054538 |
|---|---|
| DOI: | 10.1111/all.16640 |